These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35984397)

  • 1.
    Parvin M; Rahaman A; Sarkar A; Debnath S; De UC; Mandal DP; Bhattacharjee S
    J Am Nutr Assoc; 2023 Aug; 42(6):573-587. PubMed ID: 35984397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antitumor effects of herbal medicine Triphala on oral cancer by inactivating PI3K/Akt signaling pathway: based on the network pharmacology, molecular docking, in vitro and in vivo experimental validation.
    Hu S; Li S; Xu Y; Huang X; Mai Z; Chen Y; Xiao H; Ning W; Gaus S; Savkovic V; Lethaus B; Zimmerer R; Acharya A; Ziebolz D; Schmalz G; Huang S; Zhao J; Hu X
    Phytomedicine; 2024 Jun; 128():155488. PubMed ID: 38493718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined cetuximab and celecoxib treatment exhibits a synergistic anticancer effect on human oral squamous cell carcinoma in vitro and in vivo.
    Qian M; Qian D; Jing H; Li Y; Ma C; Zhou Y
    Oncol Rep; 2014 Oct; 32(4):1681-8. PubMed ID: 25328959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted disruption of PI3K/Akt/mTOR signaling pathway, via PI3K inhibitors, promotes growth inhibitory effects in oral cancer cells.
    Aggarwal S; John S; Sapra L; Sharma SC; Das SN
    Cancer Chemother Pharmacol; 2019 Mar; 83(3):451-461. PubMed ID: 30519710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of VEGFR2 and EGFR signaling cooperatively suppresses the proliferation of oral squamous cell carcinoma.
    Onda M; Ota A; Ito K; Ono T; Karnan S; Kato M; Kondo S; Furuhashi A; Hayashi T; Hosokawa Y; Kazaoka Y
    Cancer Med; 2023 Aug; 12(15):16416-16430. PubMed ID: 37341071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphonuclear myeloid-derived suppressor cells and phosphatidylinositol-3 kinase gamma are critical to tobacco-mimicking oral carcinogenesis in mice.
    Nguyen KA; DePledge LN; Bian L; Ke Y; Samedi V; Berning AA; Owens P; Wang XJ; Young CD
    J Immunother Cancer; 2023 Sep; 11(9):. PubMed ID: 37734878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumol Exerts Antitumor Effect via Inhibiting EGFR-Akt-Mcl-1 Signaling.
    Li XY; Gao F; Wang XC; Liu LL; Gan Y; Han SZ; Zhou L; Li W; Li M
    Am J Chin Med; 2023; 51(3):741-760. PubMed ID: 36869017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of Akt by methanol extracts of Impatiens balsamina L. promotes apoptosis in human oral squamous cell carcinoma cell lines.
    Shin JA; Ryu MH; Kwon KH; Choi B; Cho SD
    J Oral Pathol Med; 2015 Jul; 44(6):420-8. PubMed ID: 25212570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-186-5p inhibits the progression of oral squamous cell carcinoma by targeting ITGA6 to impair the activity of the PI3K/AKT pathway.
    Chen M; Zhang J
    J Oral Pathol Med; 2022 Apr; 51(4):322-331. PubMed ID: 35201653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4NQO induced carcinogenesis: A mouse model for oral squamous cell carcinoma.
    Sagheer SH; Whitaker-Menezes D; Han JYS; Curry JM; Martinez-Outschoorn U; Philp NJ
    Methods Cell Biol; 2021; 163():93-111. PubMed ID: 33785171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cetyltrimethylammonium Bromide Attenuates the Mesenchymal Characteristics of Hypopharyngeal Squamous Cell Carcinoma Through Inhibiting the EGFR/PI3K/AKT Signaling Pathway.
    Wu TK; Ou YC; Chen YP; Huang FM; Pan YR; Lee CJ
    Anticancer Res; 2021 Aug; 41(8):3789-3799. PubMed ID: 34281838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal downregulation of 10-formyltetrahydrofolate dehydrogenase promotes the progression of oral squamous cell carcinoma by activating PI3K/Akt/Rb pathway.
    Qu Y; He Y; Ruan H; Qin L; Han Z
    Cancer Med; 2023 Mar; 12(5):5781-5797. PubMed ID: 36336972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saikosaponin-A Exhibits Antipancreatic Cancer Activity by Targeting the EGFR/PI3K/Akt Pathway.
    Shi C; Sun L; Fang R; Zheng S; Yu M; Li Q
    Curr Pharm Biotechnol; 2023; 24(4):579-588. PubMed ID: 35692139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the EGFR/PI3K/AKT pathway limits the efficacy of trametinib treatment in head and neck cancer.
    Novoplansky O; Shnerb AB; Marripati D; Jagadeeshan S; Abu Shareb R; Conde-López C; Zorea J; Prasad M; Ben Lulu T; Yegodayev KM; Benafsha C; Li Y; Kong D; Kuo F; Morris LGT; Kurth I; Hess J; Elkabets M
    Mol Oncol; 2023 Dec; 17(12):2618-2636. PubMed ID: 37501404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promotive effects of HOXA10 antisense RNA on the stemness of oral squamous cell carcinoma stem cells through a microRNA-29a/MCL-1/phosphatidyl inositol 3-kinase/protein kinase B axis.
    Wang D
    Arch Oral Biol; 2021 Jun; 126():105114. PubMed ID: 33831733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periodontal disease affects oral cancer progression in a surrogate animal model for tobacco exposure.
    Spuldaro TR; Wagner VP; Nör F; Gaio EJ; Squarize CH; Carrard VC; Rösing CK; Castilho RM
    Int J Oncol; 2022 Jun; 60(6):. PubMed ID: 35514311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activin A regulates the epidermal growth factor receptor promoter by activating the PI3K/SP1 pathway in oral squamous cell carcinoma cells.
    Tsai CN; Tsai CL; Yi JS; Kao HK; Huang Y; Wang CI; Lee YS; Chang KP
    Sci Rep; 2019 Mar; 9(1):5197. PubMed ID: 30914776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kaempferol potentiates the sensitivity of pancreatic cancer cells to erlotinib via inhibition of the PI3K/AKT signaling pathway and epidermal growth factor receptor.
    Zhang Z; Guo Y; Chen M; Chen F; Liu B; Shen C
    Inflammopharmacology; 2021 Oct; 29(5):1587-1601. PubMed ID: 34322786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical polyethylene glycol as a novel chemopreventive agent for oral cancer via targeting of epidermal growth factor response.
    Wali RK; Kunte DP; De La Cruz M; Tiwari AK; Brasky J; Weber CR; Gibson TP; Patel A; Savkovic SD; Brockstein BE; Roy HK
    PLoS One; 2012; 7(6):e38047. PubMed ID: 22675506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane-tethered Notch1 exhibits oncogenic property via activation of EGFR-PI3K-AKT pathway in oral squamous cell carcinoma.
    Zheng Y; Wang Z; Xiong X; Zhong Y; Zhang W; Dong Y; Li J; Zhu Z; Zhang W; Wu H; Gu W; Wu Y; Wang X; Song X
    J Cell Physiol; 2019 May; 234(5):5940-5952. PubMed ID: 30515785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.